The Rest Is Science The Rest Is Science

Mapping Cancer’s Life Story

Nov 19, 2026 · 33m

Summary

World-leading cancer researcher Mariam Tuma discusses the complexities of lung cancer, including the biology of cachexia and the use of precision medicine. She highlights the PEACE autopsy study and TracerX, which reveal how cancers evolve and evade the immune system. Tuma also explains the LungVax trial, a first-in-human vaccine designed to prevent recurrence, and shares her optimistic view that collaborative, multidisciplinary efforts can eventually conquer cancer.

Topics discussed

Opening message: Hope and ambition in cancer research Episode intro and recap of previous Cancer Research UK stories The mystery of cachexia: a wasting syndrome in advanced cancer Introduction of Professor Mariam Jamalhanjani and her background From physics to medicine: Mariam's career pivot Lung cancer advancements: precision medicine and non-smokers The big questions driving cancer research today Understanding cachexia biology: why eating more doesn't help The complexity of cachexia: multiple systems and targets Team CanCan progress: tools, GDF15, and clinical trials The PEACE study: using autopsies to understand cancer spread Lessons from autopsies and the TracerX blood study LungVax: the first lung cancer prevention vaccine trial Extra-chromosomal DNA (ecDNA) and new treatment targets Optimism and the breakthrough of immunotherapy Personal stories: cervical cancer and the impact of prevention Closing message: Hope, community, and legacy Outro: Golden age of research and supporting Cancer Research UK

More from The Rest Is Science

How Fluoride Saved Our Teeth
Nov 21, 2026
What's The Deal With Boomers?
Nov 15, 2026
The Secrets Michael Keeps From Himself
Nov 12, 2026
Why Does Evolution Keep Inventing Mind Control?
Nov 8, 2026
Why Sharks Attack The Internet
Nov 5, 2026
Listen ad-free on Castria